HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%- hyaluronic acid sodium salt 0.5% / tazarotene 0.1% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%

Directions for use

fd

SIncerus Florida, LLC. Adverse reactions

we

Active, inactive

xz

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%. Cream 30 gm

sdf

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% 
hyaluronic acid sodium salt 0.5% / tazarotene 0.1% cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2094
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM0.5 g  in 100 g
TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS) TAZAROTENE0.1 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2094-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/07/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/07/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2094)

Revised: 5/2019
Document Id: 8838d911-0db3-f66e-e053-2995a90acb53
Set id: 8838d911-0db2-f66e-e053-2995a90acb53
Version: 1
Effective Time: 20190506
 
Sincerus Florida, LLC